A carregar...
Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials
Background: We review factors impacting ipilimumab-associated adverse events through the experience from National Cancer Institute (NCI)-sponsored phase I immunotherapy clinical trials. Materials and Methods: Attributable ipilimumab-related adverse events from NCI-sponsored phase I immunotherapy cli...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7185063/ https://ncbi.nlm.nih.gov/pubmed/32363000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27537 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|